超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

法國 思塔高 stago     
Satgo成立于1945年，從藥物分析起家，現成為體外診斷（IVD）行業中致力于血栓與止血研究的專業公司。

公司一覽
通過研發、生產到物流保障、市場、銷售以及國際拓展，Stago從全方位確保公司整體戰略的實施。

通過了ISO13485和ISO9001（2008）認證，Stago絕大部分的工業生產都集中在法國。而全球化發展也驅使我們將產品的研發及制造中心延伸至美國、荷蘭、德國和愛爾蘭。我們對于產品研發的投資遠大于IVD行業的平均投入。

自從1985年美國分公司成立以來，Stago的直銷網絡一直在發展。在過去的10年間，我們又陸續成立了5間分公司，它們分別是：Stago中國（2003），Stago英國（2005），拓展中東業務的Stago迪拜辦事處（2007），Stago澳大利亞/新西蘭以及Stago加拿大（2008）。

Stago旗下的公司有：Stago, Tcoag, Agrio-Bio, BioCytex, Thrombinoscope, Synapse 和 DSRV。

里程碑
Stago是由Jacques Viret（卒于2009年10月）先生在第二次世界大戰末期創立，銷售一種用于緩解消化和肝功能障礙的藥物，到今天Stago已經發展到擁有近2000名雇員，其中超過一半在法國工作。

With a staff close to 1,500 and the most advanced technologies, Diagnostica Stago formulates, manufactures and markets worldwide, the broadest range of reagents and analytical instruments in haemostasis. Diagnostica Stago devotes its research and innovative skills to the development of increasingly effective medical diagnostic products and instrumentation.

Because we are committed to a better understanding of haemostasis and thrombosis, Diagnostica Stago's creativity, supported by a team of specialized researchers, results in a range of reagents and instruments which just keeps getting better. This involves constant leading-edge research as well as the improvement of existing kits.

Selected distributors and international marketing support
Thanks to a wide international network of distributors, Diagnostica Stago is represented in more than 110 countries. Without exception, each distributor is chosen according to strict criteria regarding the performance of its team, its capabilities in after-sales services, and its commitment to knowing and promoting the Diagnostica Stago line. For the last few years, our efforts have focused primarily on the individual needs of each country and each market, taking into account their specific expectations. This is effective because of the local field activity of the sales and marketing export team.

Flexible production
Faced with a diverse and ever-increasing demand, Diagnostica Stago is finding ways of closely monitoring the evolution of markets and forecasting their development. The flexibility of our production capabilities and the proficiency of our logistics division have enabled us to respond effectively to the needs of our partners and international clients.

Your partner for the diagnosis of coagulation and thrombosis
For a long time, Diagnostica Stago has maintained a partnership with many hospital and research laboratories working on thromboembolic diseases, and blood transfusion centres. Diagnostica Stago products have a clinical application in diagnosis, in the treatment of haemostasis disorders (haemophilia, thrombosis) and in the prediction of thromboembolic risk. By the way, the assessment of thrombosis which represents one of the priorities of Diagnostica Stago is considered by the experts as the future of haemostasis.
 

Key date of STAGO's development
 

1945: Creation of Laboratoire Stago, Paris, France
1962: Stago develops its first test reagents for coagulation
1976: Stago dedicates itself exclusively to coagulation testing and becomes Diagnostica Stago
1979: Creation of the Reagent Research and Development Centre
1985: Establishment of an American subsidiary
1987: Creation of the Instrumentation Division
1992: Worldwide launch of STA?, the first fully automated coagulation analyser
2000: Addition of a new production facility in Taverny (France)
2003: Establishment of a Chinese subsidiary
2005: Establishment of an United Kingdom subsidiary
2007: Diagnostica Stago changes its logo
2008: Establishment of a AUE (Duba?) subsidiary